March 24, 2017
FDA approves EMD Serono’s rare skin cancer drug
EMD Serono, U.S. company focused on specialty care has received U.S. Food and Drug Administration (FDA) approval for its rare skin cancer drug.
Pharmaceuticals, Biotechnology and Life Sciences
Category: news
March 23, 2017
Latino population in USA have higher rates of cardio-metabolic diseases
Latino population in the United States of America have higher rates of cardio-metabolic diseases than in rest of the population, said David Kerr, director of Innovation and Research for the William Sansum Diabetes center.
March 23, 2017
Crunch week looms for Sanofi, Roche and GSK at U.S. drugs agency
Three of Europe’s top drugmakers face critical verdicts from U.S. regulators next week, with Sanofi <SASY.PA> and Roche <ROG.S> likely to win approvals for two new products, while GlaxoSmithKline <GSK.L> braces for a potential generic rival.
March 23, 2017
Teva Pharm may fire 6,000 workers – Israeli media report
Teva Pharmaceutical Industries <TEVA.TA> may fire as many as 6,000 workers worldwide as part of a multi-year efficiency plan, Israel’s Calcalist news website reported on Thursday.
March 23, 2017
Futura medical decreases loss in 2016
Futura medical, healthcare company focused on advanced transdermal technology, has announced its preliminary results for the year 2016.
March 23, 2017
£200 million to U.K. Biobank for genetics-guided drug development
A major research has been initiated, which will enable researchers to gain valuable insights to support advances in the development of new medicines for a wide range of serious and life threatening diseases.
March 23, 2017
Alcon wins FDA’s approval for its intraocular lens for cataract surgery patients
Alcon, a division of Novartis, has received approval from the US Food and Drug Administration (FDA) for its AcrySof IQ ReSTOR +2.5 Multifocal Toric intraocular lens (IOL) with Activefocus optical design for patients undergoing cataract surgery who choose to address their astigmatism and presbyopia at the same time.
March 22, 2017
Verona Pharma and QuintilesIMS in strategic agreement to develop respiratory drugs
Verona Pharma, a clinical-stage biopharmaceutical company focused on developing and commercialising innovative therapeutics for the treatment of respiratory diseases, has entered into a global strategic services agreement with QuintilesIMS, a provider of biopharmaceutical development and commercial outsourcing services.
March 22, 2017
FDA OK’s Parkinson’s disease drug
The U.S. Food and Drug Administration has approved Newron Pharmaceuticals’s Xadago (safinamide) tablets as an add-on treatment for patients with Parkinson’s disease who are currently taking levodopa/carbidopa.
March 22, 2017
Galapagos nets $7.5 million from partner for reaching milestone in a study
Galapagos NV has reached a milestone in a Phase 1 study for cystic fibrosis, it is conducting with its partner AbbVie, …